Literature DB >> 6824824

Use of aids during the first three months after total hip replacement.

R J Haworth.   

Abstract

The supply and use of aids following total hip replacement was monitored to see why therapists supplied aids and how quickly and why patients stopped using them. Postal questionnaires were sent to 163 patients with unilateral or bilateral osteoarthrosis of the hip or rheumatoid arthritis 2, 6 and 10 weeks after discharge from hospital. Patients had 2.2 aids per person on admission and 5.8 aids per person 2 weeks after discharge. They used 2.3 aids per person 10 weeks after discharge. Improvement in the pattern of walking was the main reason for supplying walking aids, safety for providing bath aids, and pain/insufficient range of movement for supplying dressing and toilet aids. The main reason for discarding aids was that patients could manage without them. Disease group, sex and the presence of other orthopaedic or medical problems influenced the use of aids but these differences were not apparent until 6 weeks after discharge.

Entities:  

Mesh:

Year:  1983        PMID: 6824824     DOI: 10.1093/rheumatology/22.1.29

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  4 in total

1.  Measuring wheelchair intervention outcomes: development of the wheelchair outcome measure.

Authors:  William B Mortenson; William C Miller; Jan Miller-Pogar
Journal:  Disabil Rehabil Assist Technol       Date:  2007-09

2.  Assistive devices: integral to the daily lives of human beings.

Authors:  M A van Kuyk-Minis
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

3.  Assistive devices: usage in patients with rheumatoid arthritis.

Authors:  I G de Boer; A J Peeters; H K Ronday; B J A Mertens; T W J Huizinga; T P M Vliet Vlieland
Journal:  Clin Rheumatol       Date:  2008-08-26       Impact factor: 2.980

4.  A qualitative study of professional and carer perceptions of the threats to safe hospital discharge for stroke and hip fracture patients in the English National Health Service.

Authors:  Justin Waring; Simon Bishop; Fiona Marshall
Journal:  BMC Health Serv Res       Date:  2016-07-25       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.